Search the Newsreel

793,292 Shares in Embecta Corp. $EMBC Purchased by Walleye Capital LLC

Walleye Capital LLC has purchased 793,292 shares of Embecta Corp. (NASDAQ:EMBC) for approximately $7.0 million, establishing a new 1.34% stake in the company. Embecta's stock has faced significant challenges, including trading near its 12-month low, missing recent earnings estimates, and cutting its dividend, alongside …

Rhinebeck Bancorp (NASDAQ:RBKB) Announces Earnings Results

Dimensional Fund Advisors LP Lowers Holdings in Becton, Dickinson and Company $BDX

Dimensional Fund Advisors LP significantly reduced its stake in Becton, Dickinson and Company (BDX) by 5.6% during the first quarter, now holding 2,271,757 shares valued at $357.1 million. This reduction comes amid other institutional investor activity and insider selling by CEO Thomas E. Polen, …

Kaplan Fox Encourages Investors of Embecta Corp. (NASDAQ: EMBC) to Contact the Firm to Learn About Their Legal Rights

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. This action follows a significant drop in Embecta's stock price after the company …

Becton Dickinson stock steadies as investors weigh recent growth metrics and margins

Becton Dickinson (BDX) stock is stable as investors evaluate the medical technology supplier's recent fiscal performance, which shows steady revenue growth, improving margins, and strong cash flow. The company reported revenue near $20 billion and consistent profit generation, supported by diversified segments including medical …

Rhinebeck Bancorp, Inc. (RBKB) awards director 10,000 shares and shows option holdings

Rhinebeck Bancorp, Inc. director William C. Irwin was granted 10,000 shares of common stock at $10.00 per share on July 21, 2026. These restricted shares will vest at 33 1/3% annually starting May 26, 2027, bringing his direct common share holdings to 50,937. Irwin …

EMBC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Embecta Corp. Stockholders Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Embecta Corp. (NASDAQ:EMBC) and its officers, inviting stockholders who purchased securities between November 25, 2025, and May 4, 2026, to join. The lawsuit alleges that Embecta made false and misleading statements about …

AcuityMD Now Trusted By More Than 500 Medical Device Companies, Including 16 of Top 20

Rapid growth reflects seismic shift toward greater use of AI across the MedTech industry BOSTON, July 22, 2026--(BUSINESS WIRE)--AcuityMD, the AI platform for MedTech, today announced it is now trusted by more than 500 medical device (MedTech) companies, including 16 of the top 20, …

Mike Garrison to Retire from BD

FRANKLIN LAKES, N.J., July 22, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Michael (Mike) Garrison has informed the company of his intent to retire after more than 20 years with BD, …

EMBC Shareholder Alert: Embecta Corp. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Levi & Korsinsky, LLP has issued a shareholder alert for Embecta Corp. (NASDAQ: EMBC) investors regarding a securities class action lawsuit. The lawsuit targets two senior executives, CEO Devdatt Kurdikar and CFO Jacob P. Elguicze, for allegedly disseminating misleading fiscal year 2026 guidance, which …

Canara Robeco AMC surges as Q1 PAT jumps 24%

Rhinebeck Bancorp (NASDAQ: RBKB) director gets 10,000-share stock award

Rhinebeck Bancorp director Christopher W. Chestney was granted 10,000 shares of common stock on July 21, 2026, priced at $10.00 per share, increasing his direct holdings to 40,940 common shares, including restricted stock. He also holds 22,875 fully vested stock options and indirect shares …

Rhinebeck Bancorp, Inc. (RBKB) director details stock and option positions

Rhinebeck Bancorp, Inc. director Suzanne Loughlin has reported her direct ownership of 34,328 shares of Common Stock and fully vested stock options for 22,875 shares, exercisable at $4.7000 per share. These holdings reflect adjustments from the company's mutual to stock conversion, including a 1.3978-to-1.00 …

Rhinebeck Bancorp (RBKB) EVP discloses 12,580-share common stock holding

Michael Vitale, EVP and Head of Commercial Banking at Rhinebeck Bancorp, Inc. (RBKB), reported direct ownership of 12,580 common shares. This amount reflects the company's 1.3978-to-1 stock exchange ratio from its mutual to stock conversion and includes restricted shares that will vest at 33 …

Rhinebeck Bancorp (RBKB) director details 2,270-share holding, vesting terms

Rhinebeck Bancorp director Patzwahl Nancy Koskey reported direct ownership of 2,270 shares of common stock, reflecting a 1.3978-to-1.00 stock exchange ratio from the company's mutual to stock conversion. The filing also detailed that shares of restricted stock will vest at 33 1/3% annually starting …

Rhinebeck Bancorp (RBKB) director details 22875 options and stock holdings

Rhinebeck Bancorp director Steven E. Howell has reported his current equity holdings, which include 22,875 fully vested stock options with an exercise price of $4.70 and an expiration date of August 25, 2030. He also directly holds 9,259 common shares and indirectly holds 6,989 …

Rhinebeck Bancorp, Inc. Announces Completion of Conversion and Offering

Rhinebeck Bancorp, Inc. (NASDAQ Capital Market:RBKB) has completed its "second-step" conversion from a two-tier mutual holding company structure to a fully-public stock holding company structure and its related offering. The company sold 8,880,210 shares of common stock at $10.00 per share, resulting in 15,638,237 …

COO Jamie Bloom receives 1000 shares at Rhinebeck Bancorp, Inc. (RBKB)

Rhinebeck Bancorp, Inc. COO Jamie J. Bloom was granted 1,000 shares of common stock at $10.00 per share, increasing his indirect 401(k) holding to 2,970 shares. This transaction is part of a Form 4 filing and reflects Bloom's updated ownership, including direct shares, ESOP …

Rhinebeck Bancorp (NASDAQ: RBKB) finishes second-step conversion and sale

Rhinebeck Bancorp, Inc. (NASDAQ: RBKB) has completed its "second-step" conversion from a two-tier mutual holding company to a fully public stock holding company, coupled with a related stock offering. The company sold 8,880,210 shares of common stock at $10.00 per share, and existing public …

Rhinebeck Bancorp Becomes Fully Public as Mutual Holding Company Ends

Rhinebeck Bancorp (NASDAQ: RBKB) has completed its second-step conversion to a fully public stock holding company, dissolving Rhinebeck Bancorp, MHC. The company also closed a stock offering, selling 8,880,210 common shares at $10.00 each, resulting in 15,638,237 common shares outstanding after an exchange ratio …

EMBC Alert: Hagens Berman Investigates Alleged Securities Law Violations at Embecta Corp. (NASDAQ: EMBC) Following Pending Class Action Litigation

Hagens Berman is investigating Embecta Corp. (NASDAQ: EMBC) for alleged securities law violations after a class action lawsuit was filed accusing the company of misrepresenting the stability of its insulin pen needle business. The lawsuit claims Embecta's assurances of a "stable" and "resilient" pen …

Rhinebeck Bancorp, Inc. Announces Subscription Offering Results and Expected Closing Date

Rhinebeck Bancorp, Inc. announced the results of its oversubscribed subscription offering related to its mutual-to-stock conversion, confirming that eligible depositors' orders will be allocated first. The company expects to close the transaction on July 21, 2026, after which existing shareholders will receive 1.3978 new …

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 17, 2026 in Embecta Corp. Lawsuit - EMBC

The Gross Law Firm is reminding shareholders of Embecta Corp. (NASDAQ: EMBC) that the lead plaintiff deadline for a class action lawsuit is August 17, 2026. The lawsuit alleges that Embecta made misleading statements regarding its fiscal results, specifically its pen needle business, leading …

Kaplan Fox Encourages Investors of Embecta Corp. (EMBC) Who Suffered Losses to Contact the Firm Before August 17, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Embecta Corp. (EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026, and suffered losses. The lawsuit stems from Embecta's Q2 fiscal 2026 results, which were …

Lawsuit Notice: $EMBC Legal News: Embecta Insulin Pen Issues and 57% Stock Drop Trigger Securities Fraud Class Action

A securities fraud class action lawsuit has been filed against Embecta Corp. (EMBC) and its executives following a 57% stock drop. The lawsuit alleges that Embecta misled investors about the strength of its insulin pen needle product category, despite facing significant competition and market …

Mrs Bectors Food shares surge 30% in 4 days after Sunil Singhania's Abakkus acquires 1% stake. Do you own?

Becton, Dickinson and Company Earnings Preview: What to Expect

BDX5385474 Bond Risk Profile

This article provides a risk profile for the Embecta Corp. 6.75% 15-FEB-2030 bond (BDX5385474 FINRA). It highlights key metrics for assessing credit risk, including security levels, inflation protection, and issuer ratings. The content encourages users to evaluate the bond's reliability and offers access to …

Becton Dickinson & Co. stock underperforms Monday when compared to competitors

Becton Dickinson & Co. (BDX) stock fell by 2.33% on Monday, closing at $154.48, which was part of a larger downturn in the stock market where the S&P 500 Index and Dow Jones Industrial Average also declined. This marked the second consecutive day of …

Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business -- HBSS

Embecta Corp. (EMBC) is facing a securities class action lawsuit for allegedly concealing competitive threats to its pen needle business, which constitutes over 70% of its total revenues. The lawsuit, filed by Hagens Berman, seeks to represent investors who purchased common stock between November …

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 13.4% Potential Upside Amid Strong Healthcare Performance

Becton, Dickinson and Company (BDX) is a healthcare stalwart with a $43.58 billion market capitalization, offering stability and growth potential. Its current stock price of $158.17, with an average analyst target price of $179.36, suggests a 13.4% upside. Strong financial fundamentals, a positive analyst …

Mrs Bectors Food extends rally following Abakkus buy

Mrs Bectors Food shares surge 25% in 3 days after Sunil Singhania's Abakkus picks up stake

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Embecta Corp.

The Rosen Law Firm is encouraging investors who purchased Embecta Corp. (NASDAQ: EMBC) common stock between November 25, 2025, and May 4, 2026, to secure legal counsel before the August 17, 2026, lead plaintiff deadline for a securities class action. The lawsuit alleges that …

Becton Dickinson stock trades steadily as investors weigh recent earnings and medical-device demand

Becton Dickinson (BDX) stock is currently reflecting a balance between defensive healthcare exposure and post-pandemic normalization, with investors focusing on recent earnings, cash flow, and market demand for medical devices. The company's diverse portfolio spans medication management, diagnostics, and interventional products, which are key …

EMBC SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Embecta Investors of Securities Class Action Lawsuit Deadline on August 17, 2026

Faruqi & Faruqi, LLP is reminding Embecta Corp. investors of the August 17, 2026, deadline to seek the role of lead plaintiff in a federal securities class action lawsuit. The lawsuit alleges that Embecta made misleading statements and concealed adverse facts about its fiscal …